Rutgers New Jersey Medical School

Rutgers University’s Resilient, Innovative Year Confronting COVID-19

March 4, 2021 sarah Jonas Corona, Coronavirus, covid, COVID-19, Emergency Use Authorization, face shields, FDA, Health, Health Care, Johnson & Johnson, Medical, Medicine, Minorities, Minority Populations, nasopharyngeal swabs, National Institutes of Health, New Jersey, NIH, NJ, Pandemic, personal protective equipment, PPE, Public Health, Research, RU, RUCDR Infinite Biologics, Rutgers, Rutgers Biomedical and Health Sciences, Rutgers New Jersey Medical School, Rutgers Robert Wood Johnson Medical School, Rutgers School of Public Health, Rutgers University, Rutgers University-Camden, Rutgers University-New Brunswick, Rutgers University-Newark, saliva test, SARS-CoV-2, Science, swabs, U.S. Food And Drug Administration, Underserved Communities, Underserved Populations, University Hospital, Vaccination, Vaccines

The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.